Patricia Meza-Meneses

Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial

R. Perez-Padilla, I. Thirión-Romero, S. Rodríguez-Llamazares, 2021, medRxiv.

Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes

N. Chavez-Tapia, M. Uribe, O. González-Chon, 2014, Therapeutics and clinical risk management.

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

Sean M. O'Brien, B. Abella, D. Angus, 2020, medRxiv.

Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination

M. Soriano-Ursúa, C. Rodríguez-Cerdeira, R. Hernández-Castro, 2021, Pharmaceutics.

Epidemiology of Systemic Mycoses in the COVID-19 Pandemic

C. Rodríguez-Cerdeira, R. Hernández-Castro, R. Pinto-Almazán, 2021, Journal of fungi.

INFECTIOUS COMPLICATIONS AS A PREDICTOR OF MORTALITY IN PATIENTS WITH NON-HODGKIN LYMPHOMA RECEIVING RITUXIMAB-CONTAINING CHEMOTHERAPY.

P. Cornejo-Juárez, P. Volkow-Fernández, D. Vilar-Compte, 2019, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes

N. Chavez-Tapia, M. Uribe, O. González-Chon, 2014 .

hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes

N. Chavez-Tapia, M. Uribe, O. González-Chon, 2014 .